Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report16 November 2017
The German Federal Ministry for the Environment, Nature Conservation and Nuclear (BMUB) has published a report on the “Assessment of the legal preconditions under which it would be possible to decommission uranium enrichment and nuclear fuel production in Germany”. It has been noted by Urenco and we are analysing it internally.
There is no new policy on this subject, and there cannot be until some time after a new German Government is formed. In the interim, we will continue to communicate with relevant parties.
An end to uranium enrichment does not appear among the legal resolutions for Germany’s phase-out of nuclear energy and Urenco's activities in Gronau are based on a permanent operating licence. Regular safety checks confirm that the uranium enrichment plant in Gronau (UAG) complies with the highest safety and quality standards.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries